More importantly, blocking the PD-1/PD-L1 axis is an efficient therapeutic approach for CHL [40,41], and PD-L1 expression level is associated with a good response to PD-1/PD-L1 inhibitors [42]. Here, CD274 is linked to classic Hodgkin lymphoma.